PharVision Advisers’s Openlane OPLN Stock Holding History

PharVision Advisers’s Portfolio OPLN Stock Details OPLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-10,209	Closed	-$294K	–	855
2025 Q3	$294K	Buy	+10,209	New	+$278K	0.17%	234

Other funds holding OPLN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

HRCM

Hawk Ridge Capital Management Los Angeles, California $2.75B AUM 20.09% 1-Year Est. Return

PharVision Advisers's OPLN Position: Q4 2025 in Review

PharVision Advisers sold out of Openlane (OPLN) in Q4 2025, closing a stake of 10,209 shares — an estimated $294K sold.

PharVision Advisers first reported a position in OPLN in Q3 2025 and held it in 1 quarter. The position peaked at $294K in Q3 2025. 299 funds tracked by Wall St. Rank hold OPLN as of Q4 2025.

PharVision Advisers reported no remaining Openlane position as of Q4 2025 after selling out during the quarter.
PharVision Advisers sold 10,209 Openlane shares in Q4 2025, an estimated $294K.
PharVision Advisers first reported a position in Openlane in Q3 2025 and held it in 1 quarter.
PharVision Advisers's Openlane position peaked at $294K in Q3 2025.
299 funds tracked by Wall St. Rank held Openlane as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.